The global Infant Heel Lancets market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Infant Heel Lancets leading manufacturers including BD, Cardinal Health, ICU Medical, Sol-Millennium Medical Group, Terumo, Owen Mumford, Germaine Laboratories, Medicore, Greiner Bio-One, Shandong Weigao Group, etc., dominate supply; the top five capture approximately % of global revenue, with BD leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Infant Heel Lancets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Infant Heel Lancets Market Report

Report Metric	Details
Report Name	Infant Heel Lancets Market
Segment by Type	Newborn Heel Lancets Premature Baby Heel Lancets
Segment by Application	Hospital Clinic
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BD, Cardinal Health, ICU Medical, Sol-Millennium Medical Group, Terumo, Owen Mumford, Germaine Laboratories, Medicore, Greiner Bio-One, Shandong Weigao Group, Sterilance Medical (Suzhou) Inc., Ningbo Meisheng Medical Equipment Co., Ltd., Jinan Haorui Biotechnology Co., Ltd., Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd., Tianjin Huahong Technology Co., Ltd., Shandong Lianfa Medical Plastic Products Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Infant Heel Lancets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Infant Heel Lancets Market report?

Ans: The main players in the Infant Heel Lancets Market are BD, Cardinal Health, ICU Medical, Sol-Millennium Medical Group, Terumo, Owen Mumford, Germaine Laboratories, Medicore, Greiner Bio-One, Shandong Weigao Group, Sterilance Medical (Suzhou) Inc., Ningbo Meisheng Medical Equipment Co., Ltd., Jinan Haorui Biotechnology Co., Ltd., Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd., Tianjin Huahong Technology Co., Ltd., Shandong Lianfa Medical Plastic Products Co., Ltd.

What are the Application segmentation covered in the Infant Heel Lancets Market report?

Ans: The Applications covered in the Infant Heel Lancets Market report are Hospital, Clinic

What are the Type segmentation covered in the Infant Heel Lancets Market report?

Ans: The Types covered in the Infant Heel Lancets Market report are Newborn Heel Lancets, Premature Baby Heel Lancets

1 Study Coverage

1.1 Introduction to Infant Heel Lancets: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Infant Heel Lancets Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Newborn Heel Lancets

1.2.3 Premature Baby Heel Lancets

1.3 Market Segmentation by Application

1.3.1 Global Infant Heel Lancets Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Infant Heel Lancets Revenue Estimates and Forecasts 2020-2031

2.2 Global Infant Heel Lancets Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Infant Heel Lancets Sales Estimates and Forecasts 2020-2031

2.4 Global Infant Heel Lancets Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Infant Heel Lancets Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Infant Heel Lancets Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Newborn Heel Lancets Market Size by Manufacturers

3.5.2 Premature Baby Heel Lancets Market Size by Manufacturers

3.6 Global Infant Heel Lancets Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Infant Heel Lancets Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Infant Heel Lancets Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Infant Heel Lancets Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Infant Heel Lancets Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Infant Heel Lancets Sales and Revenue by Type (2020-2031)

6.4 North America Infant Heel Lancets Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Infant Heel Lancets Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Infant Heel Lancets Sales and Revenue by Type (2020-2031)

7.4 Europe Infant Heel Lancets Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Infant Heel Lancets Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Infant Heel Lancets Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Infant Heel Lancets Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Infant Heel Lancets Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Infant Heel Lancets Sales and Revenue by Type (2020-2031)

9.4 Central and South America Infant Heel Lancets Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Infant Heel Lancets Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Infant Heel Lancets Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Infant Heel Lancets Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Infant Heel Lancets Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 BD

11.1.1 BD Corporation Information

11.1.2 BD Business Overview

11.1.3 BD Infant Heel Lancets Product Models, Descriptions and Specifications

11.1.4 BD Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 BD Infant Heel Lancets Sales by Product in 2024

11.1.6 BD Infant Heel Lancets Sales by Application in 2024

11.1.7 BD Infant Heel Lancets Sales by Geographic Area in 2024

11.1.8 BD Infant Heel Lancets SWOT Analysis

11.1.9 BD Recent Developments

11.2 Cardinal Health

11.2.1 Cardinal Health Corporation Information

11.2.2 Cardinal Health Business Overview

11.2.3 Cardinal Health Infant Heel Lancets Product Models, Descriptions and Specifications

11.2.4 Cardinal Health Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Cardinal Health Infant Heel Lancets Sales by Product in 2024

11.2.6 Cardinal Health Infant Heel Lancets Sales by Application in 2024

11.2.7 Cardinal Health Infant Heel Lancets Sales by Geographic Area in 2024

11.2.8 Cardinal Health Infant Heel Lancets SWOT Analysis

11.2.9 Cardinal Health Recent Developments

11.3 ICU Medical

11.3.1 ICU Medical Corporation Information

11.3.2 ICU Medical Business Overview

11.3.3 ICU Medical Infant Heel Lancets Product Models, Descriptions and Specifications

11.3.4 ICU Medical Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 ICU Medical Infant Heel Lancets Sales by Product in 2024

11.3.6 ICU Medical Infant Heel Lancets Sales by Application in 2024

11.3.7 ICU Medical Infant Heel Lancets Sales by Geographic Area in 2024

11.3.8 ICU Medical Infant Heel Lancets SWOT Analysis

11.3.9 ICU Medical Recent Developments

11.4 Sol-Millennium Medical Group

11.4.1 Sol-Millennium Medical Group Corporation Information

11.4.2 Sol-Millennium Medical Group Business Overview

11.4.3 Sol-Millennium Medical Group Infant Heel Lancets Product Models, Descriptions and Specifications

11.4.4 Sol-Millennium Medical Group Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Sol-Millennium Medical Group Infant Heel Lancets Sales by Product in 2024

11.4.6 Sol-Millennium Medical Group Infant Heel Lancets Sales by Application in 2024

11.4.7 Sol-Millennium Medical Group Infant Heel Lancets Sales by Geographic Area in 2024

11.4.8 Sol-Millennium Medical Group Infant Heel Lancets SWOT Analysis

11.4.9 Sol-Millennium Medical Group Recent Developments

11.5 Terumo

11.5.1 Terumo Corporation Information

11.5.2 Terumo Business Overview

11.5.3 Terumo Infant Heel Lancets Product Models, Descriptions and Specifications

11.5.4 Terumo Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Terumo Infant Heel Lancets Sales by Product in 2024

11.5.6 Terumo Infant Heel Lancets Sales by Application in 2024

11.5.7 Terumo Infant Heel Lancets Sales by Geographic Area in 2024

11.5.8 Terumo Infant Heel Lancets SWOT Analysis

11.5.9 Terumo Recent Developments

11.6 Owen Mumford

11.6.1 Owen Mumford Corporation Information

11.6.2 Owen Mumford Business Overview

11.6.3 Owen Mumford Infant Heel Lancets Product Models, Descriptions and Specifications

11.6.4 Owen Mumford Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Owen Mumford Recent Developments

11.7 Germaine Laboratories

11.7.1 Germaine Laboratories Corporation Information

11.7.2 Germaine Laboratories Business Overview

11.7.3 Germaine Laboratories Infant Heel Lancets Product Models, Descriptions and Specifications

11.7.4 Germaine Laboratories Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Germaine Laboratories Recent Developments

11.8 Medicore

11.8.1 Medicore Corporation Information

11.8.2 Medicore Business Overview

11.8.3 Medicore Infant Heel Lancets Product Models, Descriptions and Specifications

11.8.4 Medicore Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Medicore Recent Developments

11.9 Greiner Bio-One

11.9.1 Greiner Bio-One Corporation Information

11.9.2 Greiner Bio-One Business Overview

11.9.3 Greiner Bio-One Infant Heel Lancets Product Models, Descriptions and Specifications

11.9.4 Greiner Bio-One Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Greiner Bio-One Recent Developments

11.10 Shandong Weigao Group

11.10.1 Shandong Weigao Group Corporation Information

11.10.2 Shandong Weigao Group Business Overview

11.10.3 Shandong Weigao Group Infant Heel Lancets Product Models, Descriptions and Specifications

11.10.4 Shandong Weigao Group Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Shandong Weigao Group Recent Developments

11.11 Sterilance Medical (Suzhou) Inc.

11.11.1 Sterilance Medical (Suzhou) Inc. Corporation Information

11.11.2 Sterilance Medical (Suzhou) Inc. Business Overview

11.11.3 Sterilance Medical (Suzhou) Inc. Infant Heel Lancets Product Models, Descriptions and Specifications

11.11.4 Sterilance Medical (Suzhou) Inc. Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Sterilance Medical (Suzhou) Inc. Recent Developments

11.12 Ningbo Meisheng Medical Equipment Co., Ltd.

11.12.1 Ningbo Meisheng Medical Equipment Co., Ltd. Corporation Information

11.12.2 Ningbo Meisheng Medical Equipment Co., Ltd. Business Overview

11.12.3 Ningbo Meisheng Medical Equipment Co., Ltd. Infant Heel Lancets Product Models, Descriptions and Specifications

11.12.4 Ningbo Meisheng Medical Equipment Co., Ltd. Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Ningbo Meisheng Medical Equipment Co., Ltd. Recent Developments

11.13 Jinan Haorui Biotechnology Co., Ltd.

11.13.1 Jinan Haorui Biotechnology Co., Ltd. Corporation Information

11.13.2 Jinan Haorui Biotechnology Co., Ltd. Business Overview

11.13.3 Jinan Haorui Biotechnology Co., Ltd. Infant Heel Lancets Product Models, Descriptions and Specifications

11.13.4 Jinan Haorui Biotechnology Co., Ltd. Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Jinan Haorui Biotechnology Co., Ltd. Recent Developments

11.14 Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd.

11.14.1 Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Corporation Information

11.14.2 Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Business Overview

11.14.3 Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Infant Heel Lancets Product Models, Descriptions and Specifications

11.14.4 Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Recent Developments

11.15 Tianjin Huahong Technology Co., Ltd.

11.15.1 Tianjin Huahong Technology Co., Ltd. Corporation Information

11.15.2 Tianjin Huahong Technology Co., Ltd. Business Overview

11.15.3 Tianjin Huahong Technology Co., Ltd. Infant Heel Lancets Product Models, Descriptions and Specifications

11.15.4 Tianjin Huahong Technology Co., Ltd. Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Tianjin Huahong Technology Co., Ltd. Recent Developments

11.16 Shandong Lianfa Medical Plastic Products Co., Ltd.

11.16.1 Shandong Lianfa Medical Plastic Products Co., Ltd. Corporation Information

11.16.2 Shandong Lianfa Medical Plastic Products Co., Ltd. Business Overview

11.16.3 Shandong Lianfa Medical Plastic Products Co., Ltd. Infant Heel Lancets Product Models, Descriptions and Specifications

11.16.4 Shandong Lianfa Medical Plastic Products Co., Ltd. Infant Heel Lancets Sales, Price, Revenue and Gross Margin (2020-2025)

11.16.5 Shandong Lianfa Medical Plastic Products Co., Ltd. Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Infant Heel Lancets Industry Chain

12.2 Infant Heel Lancets Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Infant Heel Lancets Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Infant Heel Lancets Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Infant Heel Lancets Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Infant Heel Lancets Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Cardinal Health

ICU Medical

Sol-Millennium Medical Group

Terumo

Owen Mumford

Germaine Laboratories

Medicore

Greiner Bio One

SteriLance Medical (Suzhou) Inc.

Ningbo Meisheng Medical Equipment Co., Ltd.

Jinan Haorui Biotechnology Co., Ltd.

Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd.

Tianjin Huahong Technology Co., Ltd.

Shandong Lianfa Medical Plastic Products Co., Ltd.

List of Tables

Table 1. Global Infant Heel Lancets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Infant Heel Lancets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Infant Heel Lancets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Infant Heel Lancets Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Infant Heel Lancets Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Infant Heel Lancets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Infant Heel Lancets Sales by Region (2020-2025) & (K Units)

Table 8. Global Infant Heel Lancets Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Infant Heel Lancets Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Infant Heel Lancets Sales Share by Manufacturers (2020-2025)

Table 12. Global Infant Heel Lancets Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Infant Heel Lancets Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Infant Heel Lancets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infant Heel Lancets as of 2024)

Table 16. Global Infant Heel Lancets Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Infant Heel Lancets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Infant Heel Lancets Manufacturing Base and Headquarters

Table 19. Global Infant Heel Lancets Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Infant Heel Lancets Sales by Type (2020-2025) & (K Units)

Table 23. Global Infant Heel Lancets Sales by Type (2026-2031) & (K Units)

Table 24. Global Infant Heel Lancets Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Infant Heel Lancets Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Infant Heel Lancets ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Infant Heel Lancets Sales by Application (2020-2025) & (K Units)

Table 29. Global Infant Heel Lancets Sales by Application (2026-2031) & (K Units)

Table 30. Infant Heel Lancets High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Infant Heel Lancets Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Infant Heel Lancets Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Infant Heel Lancets ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Infant Heel Lancets Growth Accelerators and Market Barriers

Table 37. North America Infant Heel Lancets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Infant Heel Lancets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Infant Heel Lancets Growth Accelerators and Market Barriers

Table 40. Europe Infant Heel Lancets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Infant Heel Lancets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Infant Heel Lancets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Infant Heel Lancets Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Infant Heel Lancets Growth Accelerators and Market Barriers

Table 45. Southeast Asia Infant Heel Lancets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Infant Heel Lancets Investment Opportunities and Key Challenges

Table 47. Central and South America Infant Heel Lancets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Infant Heel Lancets Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Infant Heel Lancets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. BD Corporation Information

Table 51. BD Description and Major Businesses

Table 52. BD Product Models, Descriptions and Specifications

Table 53. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. BD Sales Value Proportion by Product in 2024

Table 55. BD Sales Value Proportion by Application in 2024

Table 56. BD Sales Value Proportion by Geographic Area in 2024

Table 57. BD Infant Heel Lancets SWOT Analysis

Table 58. BD Recent Developments

Table 59. Cardinal Health Corporation Information

Table 60. Cardinal Health Description and Major Businesses

Table 61. Cardinal Health Product Models, Descriptions and Specifications

Table 62. Cardinal Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Cardinal Health Sales Value Proportion by Product in 2024

Table 64. Cardinal Health Sales Value Proportion by Application in 2024

Table 65. Cardinal Health Sales Value Proportion by Geographic Area in 2024

Table 66. Cardinal Health Infant Heel Lancets SWOT Analysis

Table 67. Cardinal Health Recent Developments

Table 68. ICU Medical Corporation Information

Table 69. ICU Medical Description and Major Businesses

Table 70. ICU Medical Product Models, Descriptions and Specifications

Table 71. ICU Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. ICU Medical Sales Value Proportion by Product in 2024

Table 73. ICU Medical Sales Value Proportion by Application in 2024

Table 74. ICU Medical Sales Value Proportion by Geographic Area in 2024

Table 75. ICU Medical Infant Heel Lancets SWOT Analysis

Table 76. ICU Medical Recent Developments

Table 77. Sol-Millennium Medical Group Corporation Information

Table 78. Sol-Millennium Medical Group Description and Major Businesses

Table 79. Sol-Millennium Medical Group Product Models, Descriptions and Specifications

Table 80. Sol-Millennium Medical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Sol-Millennium Medical Group Sales Value Proportion by Product in 2024

Table 82. Sol-Millennium Medical Group Sales Value Proportion by Application in 2024

Table 83. Sol-Millennium Medical Group Sales Value Proportion by Geographic Area in 2024

Table 84. Sol-Millennium Medical Group Infant Heel Lancets SWOT Analysis

Table 85. Sol-Millennium Medical Group Recent Developments

Table 86. Terumo Corporation Information

Table 87. Terumo Description and Major Businesses

Table 88. Terumo Product Models, Descriptions and Specifications

Table 89. Terumo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Terumo Sales Value Proportion by Product in 2024

Table 91. Terumo Sales Value Proportion by Application in 2024

Table 92. Terumo Sales Value Proportion by Geographic Area in 2024

Table 93. Terumo Infant Heel Lancets SWOT Analysis

Table 94. Terumo Recent Developments

Table 95. Owen Mumford Corporation Information

Table 96. Owen Mumford Description and Major Businesses

Table 97. Owen Mumford Product Models, Descriptions and Specifications

Table 98. Owen Mumford Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Owen Mumford Recent Developments

Table 100. Germaine Laboratories Corporation Information

Table 101. Germaine Laboratories Description and Major Businesses

Table 102. Germaine Laboratories Product Models, Descriptions and Specifications

Table 103. Germaine Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Germaine Laboratories Recent Developments

Table 105. Medicore Corporation Information

Table 106. Medicore Description and Major Businesses

Table 107. Medicore Product Models, Descriptions and Specifications

Table 108. Medicore Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Medicore Recent Developments

Table 110. Greiner Bio-One Corporation Information

Table 111. Greiner Bio-One Description and Major Businesses

Table 112. Greiner Bio-One Product Models, Descriptions and Specifications

Table 113. Greiner Bio-One Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Greiner Bio-One Recent Developments

Table 115. Shandong Weigao Group Corporation Information

Table 116. Shandong Weigao Group Description and Major Businesses

Table 117. Shandong Weigao Group Product Models, Descriptions and Specifications

Table 118. Shandong Weigao Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Shandong Weigao Group Recent Developments

Table 120. Sterilance Medical (Suzhou) Inc. Corporation Information

Table 121. Sterilance Medical (Suzhou) Inc. Description and Major Businesses

Table 122. Sterilance Medical (Suzhou) Inc. Product Models, Descriptions and Specifications

Table 123. Sterilance Medical (Suzhou) Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Sterilance Medical (Suzhou) Inc. Recent Developments

Table 125. Ningbo Meisheng Medical Equipment Co., Ltd. Corporation Information

Table 126. Ningbo Meisheng Medical Equipment Co., Ltd. Description and Major Businesses

Table 127. Ningbo Meisheng Medical Equipment Co., Ltd. Product Models, Descriptions and Specifications

Table 128. Ningbo Meisheng Medical Equipment Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Ningbo Meisheng Medical Equipment Co., Ltd. Recent Developments

Table 130. Jinan Haorui Biotechnology Co., Ltd. Corporation Information

Table 131. Jinan Haorui Biotechnology Co., Ltd. Description and Major Businesses

Table 132. Jinan Haorui Biotechnology Co., Ltd. Product Models, Descriptions and Specifications

Table 133. Jinan Haorui Biotechnology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Jinan Haorui Biotechnology Co., Ltd. Recent Developments

Table 135. Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Corporation Information

Table 136. Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Description and Major Businesses

Table 137. Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Product Models, Descriptions and Specifications

Table 138. Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. Shiyuan Technology (Jiaxing) Medical Electronics Co., Ltd. Recent Developments

Table 140. Tianjin Huahong Technology Co., Ltd. Corporation Information

Table 141. Tianjin Huahong Technology Co., Ltd. Description and Major Businesses

Table 142. Tianjin Huahong Technology Co., Ltd. Product Models, Descriptions and Specifications

Table 143. Tianjin Huahong Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. Tianjin Huahong Technology Co., Ltd. Recent Developments

Table 145. Shandong Lianfa Medical Plastic Products Co., Ltd. Corporation Information

Table 146. Shandong Lianfa Medical Plastic Products Co., Ltd. Description and Major Businesses

Table 147. Shandong Lianfa Medical Plastic Products Co., Ltd. Product Models, Descriptions and Specifications

Table 148. Shandong Lianfa Medical Plastic Products Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 149. Shandong Lianfa Medical Plastic Products Co., Ltd. Recent Developments

Table 150. Key Raw Materials Distribution

Table 151. Raw Materials Key Suppliers

Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 153. Milestones in Production Technology Evolution

Table 154. Distributors List

Table 155. Market Trends and Market Evolution

Table 156. Market Drivers and Opportunities

Table 157. Market Challenges, Risks, and Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Infant Heel Lancets Product Picture

Figure 2. Global Infant Heel Lancets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Newborn Heel Lancets Product Picture

Figure 4. Premature Baby Heel Lancets Product Picture

Figure 5. Global Infant Heel Lancets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital

Figure 7. Clinic

Figure 8. Infant Heel Lancets Report Years Considered

Figure 9. Global Infant Heel Lancets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 10. Global Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 11. Global Infant Heel Lancets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 12. Global Infant Heel Lancets Revenue Market Share by Region (2020-2031)

Figure 13. Global Infant Heel Lancets Sales (2020-2031) & (K Units)

Figure 14. Global Infant Heel Lancets Sales (CAGR) by Region (2020-2031) (K Units)

Figure 15. Global Infant Heel Lancets Sales Market Share by Region (2020-2031)

Figure 16. Top 5 and Top 10 Manufacturers Infant Heel Lancets Sales Volume Market Share in 2024

Figure 17. Global Infant Heel Lancets Revenue Market Share Ranking (2024)

Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 19. Newborn Heel Lancets Revenue Market Share by Manufacturer in 2024

Figure 20. Premature Baby Heel Lancets Revenue Market Share by Manufacturer in 2024

Figure 21. Global Infant Heel Lancets Sales Market Share by Type (2020-2031)

Figure 22. Global Infant Heel Lancets Revenue Market Share by Type (2020-2031)

Figure 23. Global Infant Heel Lancets Sales Market Share by Application (2020-2031)

Figure 24. Global Infant Heel Lancets Revenue Market Share by Application (2020-2031)

Figure 25. North America Infant Heel Lancets Sales YoY (2020-2031) & (K Units)

Figure 26. North America Infant Heel Lancets Revenue YoY (2020-2031) & (US$ Million)

Figure 27. North America Top 5 Manufacturers Infant Heel Lancets Sales Revenue (US$ Million) in 2024

Figure 28. North America Infant Heel Lancets Sales Volume (K Units) by Type (2020- 2031)

Figure 29. North America Infant Heel Lancets Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 30. North America Infant Heel Lancets Sales Volume (K Units) by Application (2020-2031)

Figure 31. North America Infant Heel Lancets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 32. US Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 33. Canada Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 34. Mexico Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 35. Europe Infant Heel Lancets Sales YoY (2020-2031) & (K Units)

Figure 36. Europe Infant Heel Lancets Revenue YoY (2020-2031) & (US$ Million)

Figure 37. Europe Top 5 Manufacturers Infant Heel Lancets Sales Revenue (US$ Million) in 2024

Figure 38. Europe Infant Heel Lancets Sales Volume (K Units) by Type (2020-2031)

Figure 39. Europe Infant Heel Lancets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 40. Europe Infant Heel Lancets Sales Volume (K Units) by Application (2020-2031)

Figure 41. Europe Infant Heel Lancets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 42. Germany Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 43. France Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 44. U.K. Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 45. Italy Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 46. Russia Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 47. Asia-Pacific Infant Heel Lancets Sales YoY (2020-2031) & (K Units)

Figure 48. Asia-Pacific Infant Heel Lancets Revenue YoY (2020-2031) & (US$ Million)

Figure 49. Asia-Pacific Top 8 Manufacturers Infant Heel Lancets Sales Revenue (US$ Million) in 2024

Figure 50. Asia-Pacific Infant Heel Lancets Sales Volume (K Units) by Type (2020- 2031)

Figure 51. Asia-Pacific Infant Heel Lancets Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 52. Asia-Pacific Infant Heel Lancets Sales Volume (K Units) by Application (2020-2031)

Figure 53. Asia-Pacific Infant Heel Lancets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 54. Indonesia Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 55. Japan Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 56. South Korea Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 57. China Taiwan Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 58. India Infant Heel Lancets Revenue (2020-2031) & (US$ Million)

Figure 59. Central and South America Infant Heel Lancets Sales YoY (2020-2031) & (K Units)

Figure 60. Central and South America Infant Heel Lancets Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Central and South America Top 5 Manufacturers Infant Heel Lancets Sales Revenue (US$ Million) in 2024

Figure 62. Central and South America Infant Heel Lancets Sales Volume (K Units) by Type (2021-2031)

Figure 63. Central and South America Infant Heel Lancets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 64. Central and South America Infant Heel Lancets Sales Volume (K Units) by Application (2020-2031)

Figure 65. Central and South America Infant Heel Lancets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 66. Brazil Infant Heel Lancets Revenue (2020-2025) & (US$ Million)

Figure 67. Argentina Infant Heel Lancets Revenue (2020-2025) & (US$ Million)

Figure 68. Middle East, and Africa Infant Heel Lancets Sales YoY (2020-2031) & (K Units)

Figure 69. Middle East and Africa Infant Heel Lancets Revenue YoY (2020-2031) & (US$ Million)

Figure 70. Middle East and Africa Top 5 Manufacturers Infant Heel Lancets Sales Revenue (US$ Million) in 2024

Figure 71. Middle East and Africa Infant Heel Lancets Sales Volume (K Units) by Type (2021-2031)

Figure 72. South America Infant Heel Lancets Sales Revenue (US$ Million) by Type (2020-2031)

Figure 73. Middle East and Africa Infant Heel Lancets Sales Volume (K Units) by Application (2020-2031)

Figure 74. Middle East and Africa Infant Heel Lancets Sales Revenue (US$ Million) by Application (2020-2031)

Figure 75. GCC Countries Infant Heel Lancets Revenue (2020-2025) & (US$ Million)

Figure 76. Turkey Infant Heel Lancets Revenue (2020-2025) & (US$ Million)

Figure 77. Egypt Infant Heel Lancets Revenue (2020-2025) & (US$ Million)

Figure 78. South Africa Infant Heel Lancets Revenue (2020-2025) & (US$ Million)

Figure 79. Infant Heel Lancets Industry Chain Mapping

Figure 80. Regional Infant Heel Lancets Manufacturing Base Distribution (%)

Figure 81. Global Infant Heel Lancets Production Market Share by Region (2020-2031)

Figure 82. Infant Heel Lancets Production Process

Figure 83. Regional Infant Heel Lancets Production Cost Structure

Figure 84. Channels of Distribution (Direct Vs Distribution)

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions